1,391 results on '"Latini, Roberto A."'
Search Results
52. Thirty-Day Outcomes After Unrestricted Implantation of Bioresorbable Vascular Scaffold (from the Prospective RAI Registry)
53. Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart Failure
54. Final shape of biovascular scaffolds and clinical outcome. Results from a multicenter all-comers study with intravascular imaging
55. Pentraxin-3, Troponin T, N-Terminal Pro-B-Type Natriuretic Peptide in Septic Patients
56. Prospective Evaluation of Clinico-Pathological Predictors of Postoperative Atrial Fibrillation: An Ancillary Study From the OPERA Trial
57. Angiographic performance of a novel sirolimus-coated balloon in native coronary lesions: the FAtebenefratelli SIrolimus COated NATIVES prospective registry
58. A low plasma 1,25(OH)2 vitamin D/PTH (1–84) ratio predicts worsening of renal function in patients with chronic heart failure
59. Kitcre knock-in mice fail to fate-map cardiac stem cells
60. Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study
61. Amplitude Spectrum Area of ventricular fibrillation to guide defibrillation: a small open-label, pseudo-randomized controlled multicenter trial
62. Red blood cell oleic acid levels reflect olive oil intake while omega-3 levels reflect fish intake and the use of omega-3 acid ethyl esters: The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico–Heart Failure trial
63. Effects of dipeptidyl peptidase-4 (DPP-4) inhibition on angiogenesis and hypoxic injury in type 2 diabetes
64. Usefulness of High-Sensitivity Cardiac Troponin T for the Identification of Outlier Patients With Diffuse Coronary Atherosclerosis and Low-Risk Factors
65. Novel biomarkers and therapies in cardiorenal syndrome
66. Circulating Cardiac Biomarkers and Outcome
67. Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure: The HOMAGE Study
68. Radial artery perforation: when a friend turns against you
69. A novel echocardiographic method closely agrees with cardiac magnetic resonance in the assessment of left ventricular function in infarcted mice
70. Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial
71. Pentraxins and Atherosclerosis
72. Markers of neutrophil mediated inflammation associate with disturbed continuous electroencephalogram after out of hospital cardiac arrest
73. 445 Effect of indoleamine 2,3-dioxygenase-1 deficiency on long term left ventricle remodeling in a murine model of myocardial infarction
74. Fish Oil and Perioperative Bleeding: Insights From the OPERA Randomized Trial
75. Procalcitonin and Presepsin as Prognostic Markers After Out-of-Hospital Cardiac Arrest
76. The authors reply
77. Platelet Drop and Fibrinolytic Shutdown in Patients With Sepsis
78. Duration of Untreated Cardiac Arrest and Clinical Relevance of Animal Experiments: The Relationship Between the “No-Flow” Duration and the Severity of Post-Cardiac Arrest Syndrome in a Porcine Model
79. Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis
80. Circulating microRNA‐132 levels improve risk prediction for heart failure hospitalization in patients with chronic heart failure
81. Characterization of the Cardiac Structure and Function of Conscious D2.B10- Dmd mdx /J (D2- mdx) mice from 16–17 to 24–25 Weeks of Age.
82. Septic shock-3 vs 2: an analysis of the ALBIOS study
83. Cardiac Fibrosis and Aging
84. Angiotensin-(1-7) improves oxygenation, while reducing cellular infiltrate and fibrosis in experimental Acute Respiratory Distress Syndrome
85. Cardiac Remodeling, Circulating Biomarkers and Clinical Events in Patients with a History of Atrial Fibrillation. Data from the GISSI-AF Trial
86. Early kynurenine pathway activation following cardiac arrest in rats, pigs, and humans
87. Tubular Damage and Worsening Renal Function in Chronic Heart Failure
88. Stents recubiertos o farmacoactivos en aneurismas, resultados del Registro Internacional de Aneurismas Coronarios (CAAR)
89. Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure
90. Optical coherence tomography, intravascular ultrasound or angiography guidance for distal left main coronary stenting. The ROCK cohort II study
91. Abstract 16367: Treatment With Insulin is Associated With Worse Outcome in Patients With Chronic Heart Failure and Diabetes
92. Research update for articles published in EJCI in 2015
93. Clinical and angiographic outcome of a single center, real world population treated with a dedicated technique of implantation for bioresorbable vascular scaffolds. The FAtebenefratelli Bioresorbable Vascular Scaffold (FABS) registry
94. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
95. First reported use of drug‐coated balloon for bioresorbable in‐scaffold restenosis
96. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial
97. The Heart in Diabetes: Results of Trials
98. Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial
99. Circulating levels and prognostic cut‐offs of sST2, hs‐cTnT, and NT‐proBNP in women vs. men with chronic heart failure
100. Comparing and contrasting risk factors for heart failure in patients with and without history of myocardial infarction: data from HOMAGE and the UK Biobank
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.